Interestingly, in addition to its more lethal effect on tumor cells than other PI3K-Akt-mTOR pathway inhibitors, paxalisib was non-toxic to normal skin cells, including keratinocytes and fibroblasts [119]. The gene discussed is MTOR; the disease is neoplasm.